Highlights
NASDAQ: UTHR       United Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
121.19   -1.52 (1.24%)  121.00 - 123.70  342,591

Overview

Avg Volume (4 weeks):0
4 Weeks Range:119.54 - 141.82
52 Weeks Range:97.52 - 169.89
Average Price Target: 147.00
Price Target Upside/Downside: +25.81

Headlines



No recent Headlines for this stock.


Business Background

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.

  Be the first to like this.
 


 

4459  2643  565  656 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 24.215+0.585 
 JNUG 4.368-0.882 
 BABY 40.85+0.25 
 AKS 6.49-0.63 
 NUGT 8.06-1.30 
 SPY 238.79+1.62 
 GDX 22.115-1.085 
 ABX 17.083-1.957 
 FCX 12.915+0.685 
 XLF 23.965+0.285 
Partners & Brokers